drugset / Trial / NCT07345689
A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the pharmacokinetic profile and safety of anaprazole sodium in adult subjects, particularly including the elderly and those with renal or hepatic impairment.
Timeline
- Start
- 2026-01-30
- Primary completion
- 2026-10-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anaprazole | Other / unclassified | 20 mg | — |